Medeze Singapore
  • Home
  • About Us
    • Company Overview
    • Medeze Group
    • Founder
    • Scientific Team
    • Our Facilities
    • Our Services
  • Research & Development
    • Cornea
    • Cornea Regeneration
    • Our Technology
    • Current Research
    • Future Pipeline
  • Adult Stem Cell Banking
    • What are Stem Cells
    • Mesenchymal stem cells
    • Banking for Adult MSC
    • Uses of Stem Cell
    • Why Bank with Medeze?
    • Getting started
  • Resources
    • Educational
    • FAQs
  • Contact
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu

Our technology

At Medeze, we marry the cutting edge nanotechnologies with stem cell sciences to serve your regenerative needs. Nanomedicine is the critical tool for developing successful lab-grown organs as it allows us to design the building block structure and mimic natural tissue patterning precisely at nano-scale. With our expertise in using nanomedicine, we choose to focus working on adult stem cells for benefits of

  1. their genetic safety over their embryonic counterparts,
  2. their autologous applications to bypass immune rejections and complication risks,
  3. their richness of secreted factors for effective healing, and
  4. their plasticity and proliferative capacity over somatic cells to become your needed tissues.

Our technologies are designed to be better than cornea from human donor. We ensure quality of corneal endothelium. Often times, endothelial dysfunction occurs in cornea obtained from human donor; therefore, causing corneal graft failure. To further reduce graft failure, our cell collections provide immunological similarities. In high-risk individuals, mismatches of immunological profiles are also a major cause of endothelial dysfunction and graft failure.

In 2015, the European Commission has recently approved limbal stem cell product, setting a milestone to use cell replacement therapy to restore vision.

  • Cornea
  • Cornea Regeneration
  • Our Technology
  • Current Research
  • Future Pipeline

A DIVISION OF
MEDEZE GROUP

MEDEZE SINGAPORE

Medeze Singapore is the Research & Development division of Medeze Thailand. Medeze Group focuses on adipose-derived stem cell banking, regenerative therapies and research into adipose derived stem cells as organ replacements.

LOCATION

Medeze Group Pte Ltd
50 Science Park Road, #04-03, The Kendall, Singapore 117406

T: +65 6909 0558

Copyright ©2025 Medeze Group Pte Ltd. All rights reserved. Use of this site constitutes acceptance of our Terms of use and Privacy Policy | PDPA
Scroll to top Scroll to top Scroll to top